These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25154811)

  • 1. Cell-based therapies for the preterm infant.
    Zhu D; Wallace EM; Lim R
    Cytotherapy; 2014 Dec; 16(12):1614-28. PubMed ID: 25154811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
    Chang KA; Lee JH; Suh YH
    J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regenerative medicine: future impact on clinical therapies and society.
    Kargul J; Laurent GJ; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Nov; 56():1. PubMed ID: 25461768
    [No Abstract]   [Full Text] [Related]  

  • 4. Nanotherapies for micropreemies: Stem cells and the secretome in bronchopulmonary dysplasia.
    Lesage F; Thébaud B
    Semin Perinatol; 2018 Nov; 42(7):453-458. PubMed ID: 30376986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential benefits of cell therapy in coronary heart disease.
    Grimaldi V; Mancini FP; Casamassimi A; Al-Omran M; Zullo A; Infante T; Napoli C
    J Cardiol; 2013 Nov; 62(5):267-76. PubMed ID: 23834957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration.
    Emmert MY; Hitchcock RW; Hoerstrup SP
    Adv Drug Deliv Rev; 2014 Apr; 69-70():254-69. PubMed ID: 24378579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparing regenerative therapies for clinical application: proposals for responsible translation.
    Shapiro SA; Smith CG; Arthurs JR; Master Z
    Regen Med; 2019 Feb; 14(2):77-84. PubMed ID: 30651044
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell Therapy for Bronchopulmonary Dysplasia: Promises and Perils.
    Möbius MA; Thébaud B
    Paediatr Respir Rev; 2016 Sep; 20():33-41. PubMed ID: 27425012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regenerative cell and tissue-based therapies for pulmonary arterial hypertension.
    Foster WS; Suen CM; Stewart DJ
    Can J Cardiol; 2014 Nov; 30(11):1350-60. PubMed ID: 25442435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based therapy approaches: the hope for incurable diseases.
    Buzhor E; Leshansky L; Blumenthal J; Barash H; Warshawsky D; Mazor Y; Shtrichman R
    Regen Med; 2014; 9(5):649-72. PubMed ID: 25372080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CellCAN: a unique enabler of regenerative medicine and cell therapy in Canada.
    Roy DC; Alarco AM; Isasi R
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():24-8. PubMed ID: 25457957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell biology and regenerative medicine for neonatal lung diseases.
    Kang M; Thébaud B
    Pediatr Res; 2018 Jan; 83(1-2):291-297. PubMed ID: 28922348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research).
    Thébaud B; Lalu M; Renesme L; van Katwyk S; Presseau J; Thavorn K; Cobey KD; Hutton B; Moher D; Soll RF; Fergusson D
    Stem Cells Transl Med; 2021 Jul; 10(7):968-975. PubMed ID: 33570257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Translation of Regenerative Therapies.
    Allickson JG
    Clin Pharmacol Ther; 2017 Jan; 101(1):28-30. PubMed ID: 27806427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced cell therapeutics are changing the clinical landscape: will mesenchymal stromal cells be a part of it?
    Schäfer R
    BMC Med; 2019 Mar; 17(1):53. PubMed ID: 30832655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regenerative therapies in neonatology: clinical perspectives.
    Gortner L; Felderhoff-Müser U; Monz D; Bieback K; Klüter H; Jellema R; Kramer BW; Keller M; Reiss I; Horn PA; Giebel B
    Klin Padiatr; 2012 Jul; 224(4):233-40. PubMed ID: 22718085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell-based treatment of kidney diseases.
    Pan B; Fan G
    Exp Biol Med (Maywood); 2020 May; 245(10):902-910. PubMed ID: 32281411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Strategies for Niche-Dependent Cell Conversion to Assist Stem Cell Therapy.
    Del Sol A; Okawa S; Ravichandran S
    Trends Biotechnol; 2019 Jul; 37(7):687-696. PubMed ID: 30782480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical biosafety evaluation of cell-based therapies: emerging global paradigms.
    Basu J; Assaf BT; Bertram TA; Rao M
    Toxicol Pathol; 2015 Jan; 43(1):115-25. PubMed ID: 25476796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials.
    Mizuno H
    Curr Opin Mol Ther; 2010 Aug; 12(4):442-9. PubMed ID: 20677095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.